Details

Notice to stakeholders: Release of guidance document: Information and submission requirements for biosimilar biologic drugs for the addition of an indication where there is no/minimal data required to accompany the submission - Canada.ca

Metadata and links for an archived snapshot.

Source: Health Canada
Date: Jan 2, 2026 · edition #6
Timestamp: 2026-01-02T09:54:47.462Z
Language: en
Original URL: https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/notice-stakeholders-guidance-biosimilar-biologic-drugs-submission-requirements-no-minimal-data.html?wbdisable=true
Replay URL: https://replay.healtharchive.ca/job-6/20260102095447/https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/notice-stakeholders-guidance-biosimilar-biologic-drugs-submission-requirements-no-minimal-data.html?wbdisable=true#ha_snapshot=433285
ID: 433285
Status: 200
Type: text/html

Independent archive · Not an official government website. For up-to-date recommendations, always consult the official source website.

Other snapshots